• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者破伤风、白喉、百日咳和脊髓灰质炎的疫苗接种覆盖率及自我报告疫苗接种状态的有效性

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis.

作者信息

Langhorst Silvan Elias, Frahm Niklas, Hecker Michael, Mashhadiakbar Pegah, Streckenbach Barbara, Baldt Julia, Heidler Felicita, Zettl Uwe Klaus

机构信息

Department of Neurology, Neuroimmunology Section, Rostock University Medical Center, Gehlsheimer Str. 20, 18147 Rostock, Germany.

Department of Neurology, Ecumenic Hainich Hospital, Pfafferode 102, 99974 Mühlhausen, Germany.

出版信息

J Pers Med. 2022 Apr 23;12(5):677. doi: 10.3390/jpm12050677.

DOI:10.3390/jpm12050677
PMID:35629100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9146089/
Abstract

Multiple sclerosis (MS) is a chronic immune-mediated disease with a neurodegenerative component of the central nervous system. Immunomodulatory therapy can increase the risk of infection, which is a particular risk for MS patients. Therefore, a complete vaccination status is of utmost importance as protection against vaccine-preventable infectious diseases. Our aim was to investigate the vaccination status, vaccination card knowledge and the vaccination behavior of MS patients with regard to vaccinations against tetanus, diphtheria, pertussis and poliomyelitis. Three hundred twenty-seven patients with MS were evaluated by anamnesis, clinical examination, structured interview and vaccination card control in this two-center study. Based on the recommendations of the Robert Koch Institute, we assessed the completeness of the vaccination status of the examined vaccinations. Furthermore, a comparative analysis of patients with complete/incomplete or correctly/wrongly self-reported vaccination status was performed. In the cohort analyzed, the vaccination coverage was 79.5% for tetanus, 79.2% for diphtheria, 74.8% for pertussis and 84.8% for poliomyelitis. The assumed vaccination status was higher for tetanus (86.5%) and lower for diphtheria (69.4%), pertussis (61.2%) and poliomyelitis (75.9%). Patients who were unvaccinated or only partially vaccinated against tetanus had received vaccination advice from a physician less often in the past year (13.4 vs. 36.9%, p < 0.001) and had no one to check the vaccination card more often (35.8 vs. 12.3%, p < 0.001). High sensitivity (93.7%) and low specificity (30.3%) were determined regarding the validity of self-reported tetanus vaccination status. Patients with a correctly reported tetanus vaccination status were more likely to have their vaccination card checked by a physician than those who overestimated or underestimated their vaccination status (76.7 vs. 63.0/43.8%, p = 0.002). Similar findings were seen with regard to diphtheria, pertussis and poliomyelitis vaccination. Patients without a regular vaccination card control (17.1%) were more likely to be male (44.6 vs. 29.4%, p = 0.037), had fewer siblings on average (1.1 vs. 1.6, p = 0.016), dealt less frequently with the issue of vaccination in the past year (32.1 vs. 69.3%, p < 0.001) and more frequently had the wish to receive vaccination advice (48.2 vs. 34.4%, p = 0.030) than patients in whom the vaccination card was checked regularly by a physician. To minimize the risk of infection in MS patients, treating physicians should provide regular vaccination counseling and perform vaccination card controls, as these factors are associated with a higher vaccination coverage and a higher validity of self-reported vaccination statuses.

摘要

多发性硬化症(MS)是一种慢性免疫介导疾病,具有中枢神经系统的神经退行性成分。免疫调节疗法会增加感染风险,这对MS患者来说是一项特殊风险。因此,完整的疫苗接种状况对于预防疫苗可预防的传染病至关重要。我们的目的是调查MS患者在破伤风、白喉、百日咳和脊髓灰质炎疫苗接种方面的疫苗接种状况、疫苗接种卡知识和疫苗接种行为。在这项双中心研究中,通过问诊、临床检查、结构化访谈和疫苗接种卡核查对327例MS患者进行了评估。根据罗伯特·科赫研究所的建议,我们评估了所检查疫苗接种状况的完整性。此外,还对疫苗接种状况完整/不完整或自我报告正确/错误的患者进行了比较分析。在所分析的队列中,破伤风疫苗接种覆盖率为79.5%,白喉为79.2%,百日咳为74.8%,脊髓灰质炎为84.8%。假定的疫苗接种状况破伤风较高(86.5%),白喉(69.4%)、百日咳(61.2%)和脊髓灰质炎(75.9%)较低。过去一年中,未接种或仅部分接种破伤风疫苗的患者从医生处获得疫苗接种建议的频率较低(13.4%对36.9%,p<0.001),且无人检查疫苗接种卡的频率较高(35.8%对12.3%,p<0.001)。关于自我报告的破伤风疫苗接种状况的有效性,确定其敏感性高(93.7%)而特异性低(30.3%)。自我报告破伤风疫苗接种状况正确的患者比高估或低估其疫苗接种状况的患者更有可能让医生检查其疫苗接种卡(76.7%对63.0%/43.8%,p=0.002)。在白喉、百日咳和脊髓灰质炎疫苗接种方面也观察到类似结果。与医生定期检查疫苗接种卡的患者相比,没有定期检查疫苗接种卡的患者(17.1%)更可能为男性(44.6%对29.4%,p=0.037),平均兄弟姐妹较少(1.1对1.6,p=0.016),过去一年中较少处理疫苗接种问题(32.1%对69.3%,p<0.001),且更频繁地希望获得疫苗接种建议(48.2%对34.4%,p=0.030)。为了将MS患者感染的风险降至最低水平,主治医生应提供定期的疫苗接种咨询并进行疫苗接种卡核查,因为这些因素与更高的疫苗接种覆盖率和更高的自我报告疫苗接种状况有效性相关。

相似文献

1
Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis.多发性硬化症患者破伤风、白喉、百日咳和脊髓灰质炎的疫苗接种覆盖率及自我报告疫苗接种状态的有效性
J Pers Med. 2022 Apr 23;12(5):677. doi: 10.3390/jpm12050677.
2
Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers.成人旅行者破伤风、白喉、百日咳和脊髓灰质炎疫苗接种。
Travel Med Infect Dis. 2010 May;8(3):155-60. doi: 10.1016/j.tmaid.2010.02.007. Epub 2010 Mar 19.
3
Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.2013 年至 2017 年期间法国白喉、破伤风、脊髓灰质炎和百日咳加强疫苗接种的疫苗接种覆盖率:基于国家卫生系统真实世界数据的分析结果。
Vaccine. 2021 Jan 15;39(3):505-511. doi: 10.1016/j.vaccine.2020.12.021. Epub 2020 Dec 21.
4
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.在过去20年未接种含白喉和破伤风疫苗的40岁及以上成年人中,一剂白喉、破伤风、无细胞百日咳和脊髓灰质炎疫苗(Repevax®)后再接种两剂白喉、破伤风和脊髓灰质炎疫苗(Revaxis®)的免疫原性和安全性。
Vaccine. 2014 Jun 30;32(31):3942-9. doi: 10.1016/j.vaccine.2014.05.034. Epub 2014 May 19.
5
Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register.丹麦疫苗接种登记处中破伤风、白喉、百日咳和脊髓灰质炎加强疫苗接种的 5 年漏报率。
BMC Public Health. 2020 Nov 10;20(1):1681. doi: 10.1186/s12889-020-09816-w.
6
Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.白喉-破伤风-百日咳和脊髓灰质炎疫苗单剂足以在大多数移民儿童中引发破伤风加强型反应。
Vaccine. 2019 Oct 8;37(43):6441-6446. doi: 10.1016/j.vaccine.2019.08.089. Epub 2019 Sep 12.
7
Association between social vulnerability and influenza and tetanus-diphtheria-acellular pertussis vaccination in pregnant and postpartum individuals.社会脆弱性与孕妇和产后个体流感和破伤风、白喉、无细胞百日咳疫苗接种之间的关联。
Am J Obstet Gynecol MFM. 2022 May;4(3):100603. doi: 10.1016/j.ajogmf.2022.100603. Epub 2022 Feb 28.
8
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.一项 III 期、开放性标签、随机多中心研究,旨在评估在英国 3 至 4 岁健康儿童中,同时接种麻疹-腮腺炎-风疹疫苗时,两种不同低剂量抗原白喉-破伤风-无细胞百日咳-脊髓灰质炎疫苗加强剂量的免疫原性和安全性。
Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22.
9
Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial.卡介苗和白喉破伤风百日咳联合灭活脊髓灰质炎疫苗接种的相互作用、非特异性免疫效应:一项探索性、随机试验。
Clin Infect Dis. 2020 Jan 16;70(3):455-463. doi: 10.1093/cid/ciz246.
10
Diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influenzae type b vaccinations and risk of eczema and recurrent wheeze in the first year of life: the KOALA Birth Cohort Study.白喉、百日咳、脊髓灰质炎、破伤风和b型流感嗜血杆菌疫苗接种与生命第一年患湿疹和复发性喘息的风险:考拉出生队列研究
Pediatrics. 2007 Feb;119(2):e367-73. doi: 10.1542/peds.2006-1479.

引用本文的文献

1
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study.破伤风和白喉类毒素疫苗在多发性硬化症患者中的应用:一项真实世界的前瞻性、开放标签、多中心研究。
Vaccines (Basel). 2025 Apr 24;13(5):451. doi: 10.3390/vaccines13050451.
2
Public Health Surveillance of Pediatric Polio in Pakistan: A Cohort Study.巴基斯坦小儿麻痹症的公共卫生监测:一项队列研究。
Cureus. 2024 Jul 25;16(7):e65356. doi: 10.7759/cureus.65356. eCollection 2024 Jul.
3
Vaccination frequency in people newly diagnosed with multiple sclerosis.

本文引用的文献

1
Vaccination and immunotherapies in neuroimmunological diseases.神经免疫性疾病的疫苗接种和免疫疗法。
Nat Rev Neurol. 2022 May;18(5):289-306. doi: 10.1038/s41582-022-00646-5. Epub 2022 Apr 6.
2
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.纵向分析显示,多发性硬化症与 Epstein-Barr 病毒的高患病率相关。
Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.
3
Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
新发多发性硬化症患者的疫苗接种频率。
Mult Scler. 2023 Dec;29(14):1831-1840. doi: 10.1177/13524585231199084. Epub 2023 Oct 13.
严重急性呼吸综合征冠状病毒 2 型大流行时期自身免疫性疾病患者的疫苗接种设定:以多发性硬化症患者为例的纵向多中心研究。
Eur Neurol. 2022;85(2):104-111. doi: 10.1159/000519582. Epub 2021 Nov 5.
4
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.遗传、环境和生活方式因素对端粒加速损耗的影响及其对多发性硬化症风险和严重程度的贡献。
Biomolecules. 2021 Oct 13;11(10):1510. doi: 10.3390/biom11101510.
5
Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.多发性硬化症和视神经脊髓炎谱系障碍的治疗选择
Curr Pharm Des. 2022;28(6):428-436. doi: 10.2174/1381612827666210920151231.
6
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic.新冠疫情时代的疫苗接种与多发性硬化症
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1033-1043. doi: 10.1136/jnnp-2021-326839. Epub 2021 Aug 5.
7
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.多发性硬化症长期数据存储库的机遇与挑战:德国多发性硬化症注册处 20 周年。
Sci Rep. 2021 Jun 25;11(1):13340. doi: 10.1038/s41598-021-92722-x.
8
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.全球多发性硬化症患病率上升:第三版多发性硬化症图谱的见解。
Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11.
9
Effects of MS disease-modifying therapies on responses to vaccinations: A review.多发性硬化症疾病修正疗法对疫苗反应的影响:综述。
Mult Scler Relat Disord. 2020 Oct;45:102439. doi: 10.1016/j.msard.2020.102439. Epub 2020 Aug 1.
10
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018].[德国的多发性硬化症:德国多发性硬化症注册中心2014 - 2018年的最新分析]
Fortschr Neurol Psychiatr. 2020 Jul;88(7):436-450. doi: 10.1055/a-0985-4124. Epub 2020 Jul 27.